Copyright
©The Author(s) 2025.
World J Clin Cases. Mar 26, 2025; 13(9): 99463
Published online Mar 26, 2025. doi: 10.12998/wjcc.v13.i9.99463
Published online Mar 26, 2025. doi: 10.12998/wjcc.v13.i9.99463
Patient characteristics | N = 62 |
Sex | |
Male | 20 (32.26) |
Female | 42 (67.74) |
Age group (years) | |
≤ 50 | 2 (3.22) |
51-65 | 2 (3.22) |
> 65 | 58 (93.55) |
Location | |
Area H | 19 (30.65) |
Area M | 43 (69.35) |
Size of tumor (cm2), mean ± SD | 2.73 ± 4.60 |
Invasion depth (mm), mean ± SD | 4.06 ± 3.62 |
Lymphovascular invasion | |
+ | 3 |
- | 59 |
Perineural invasion | |
+ | 3 |
- | 59 |
DM | |
+ | 9 |
- | 53 |
HTN | |
+ | 27 |
- | 35 |
Characteristics | N = 62 |
Area H | 19 (30.65) |
Eyelid | 5 (8.06) |
Nose | 3 (4.84) |
Lip | 5 (8.06) |
Chin | 2 (3.23) |
Ear | 4 (6.46) |
Area M | 43 (69.35) |
Forehead | 11 (17.74) |
Scalp | 3 (4.84) |
Cheek | 29 (46.77) |
Characteristics | HPV (-) | HPV (+) | High-risk HPV | P value | The p53 (-) | The p53 (+) | P value | The p16 (-) | The p16 (+) | P value |
n | 57 | 5 | 3 | - | 17 | 45 | - | 38 | 24 | - |
Sex | ||||||||||
Male | 20 (35.09) | 0 (0.00) | 0 (0.00) | 0.165 | 8 (47.06) | 12 (26.67) | 0.125 | 14 (36.84) | 6 (25.00) | 0.331 |
Female | 37 (64.91) | 5 (100.00) | 3 (100.00) | - | 9 (52.94) | 33 (73.33) | - | 24 (63.16) | 18 (75.00) | - |
Age group | ||||||||||
≤ 50 years | 2 (3.51) | 0 (0.00) | 0 (0.00) | > 0.99 | 1 (5.88) | 1 (2.22) | 0.733 | 1 (2.63) | 1 (4.17) | 0.768 |
51-65 years | 2 (3.51) | 0 (0.00) | 0 (0.00) | - | 0 (0.00) | 2 (4.44) | - | 2 (5.26) | 0 (0.00) | - |
> 65 years | 53 (92.98) | 5 (100.00) | 3 (100.00) | - | 16 (94.12) | 42 (93.33) | - | 35 (92.11) | 23 (95.83) | - |
HPV | ||||||||||
Negative | - | - | - | - | 16 (94.12) | 41 (91.11) | > 0.99 | 35 (92.11) | 22 (91.67) | > 0.99 |
Positive | - | - | 3 (60.00) | - | 1 (5.88) | 4 (8.89) | - | 3 (7.89) | 2 (8.33) | - |
Location | - | - | - | - | - | - | - | - | - | - |
Area H | 18 (31.58) | 1 (20.00) | 0 (0.00) | > 0.99 | 3 (17.65) | 16 (35.56) | 0.172 | 13 (34.21) | 6 (25.00) | 0.444 |
Area M | 39 (68.42) | 4 (80.00) | 3 (100.00) | - | 14 (82.35) | 29 (64.44) | - | 25 (65.79) | 18 (75.00) | - |
Recurrence | ||||||||||
Yes | 15 (26.32) | 3 (60.00) | 2 (66.67) | 0.045 | 2 (11.76) | 16 (35.56) | 0.022 | 6 (15.79) | 12 (50.00) | 0.007 |
No | 42 (73.68) | 2 (40.00) | 1 (33.33) | - | 15 (88.24) | 29 (64.44) | - | 32 (84.21) | 12 (50.00) | - |
Metastasis | ||||||||||
Yes | 8 (14.04) | 2 (40.00) | 1 (33.33) | 0.037 | 1 (5.88) | 9 (20.00) | 0.041 | 3 (7.89) | 8 (33.33) | 0.015 |
No | 49 (85.96) | 3 (60.00) | 2 (66.67) | - | 16 (94.12) | 36 (80.00) | - | 35 (92.11) | 16 (66.67) | - |
- Citation: Nam HJ, Ryu H, Lee DW, Byeon JY, Kim JH, Lee JH, Lim S, Choi HJ. Expression rates of p16, p53 in head and neck cutaneous squamous cell carcinoma based on human-papillomavirus positivity. World J Clin Cases 2025; 13(9): 99463
- URL: https://www.wjgnet.com/2307-8960/full/v13/i9/99463.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v13.i9.99463